Current Funding Opportunities
Smilow Compassionate Caregiver Awards
The Smilow Compassionate Caregiver Awards celebrate caregivers who put in their whole heart to take excellent care of our patients, advocate for our patients, and work in partnership with the healthcare team to ensure the care plan is followed to achieve the treatment goal.
Three awards will be given to honor a Physician, Nurse, and Social Worker.
Deadline: December 19, 2014
The Smilow Achievement Award
The Smilow Achievement Award will be presented to a role model who has made a significant contribution to the culture and patient care at Smilow Cancer Hospital or at our Care Centers. Their career has demonstrated a sustained and lasting contribution to the field of oncology and their influence has made a positive impact on care for our patients.
One award will be given to honor an individual whose influence, mentorship and positive impact on cancer care has made a positive difference at Smilow Cancer Hospital.
Deadline: December 19, 2014
YCCI Clinical and Community Research Scholar Awards
We are pleased to announce a request for applications for YCCI Clinical and Community-Based Research Scholar Awards, which will provide salary and/or research funds to a select number of junior faculty members who are strongly committed to careers in clinical and/or community-based research. Individuals must be nominated by a department chair, division head/section chief, or center/program director. Awards will be for a total of 2 years. Funds can be requested to cover up to 75% of an individual’s salary (with a maximum of $100,000 per year including fringe benefits) and up to $20,000 of research support per year for a research project.
Deadline for LOI: December 12, 2014 at 5:00 PM
YCCI Pilot Awards
The Yale Center for Clinical Investigation (YCCI) is pleased to announce the 2014 round of pilot grants.
YCCI’s pilot program is a funding venue for conducting small-scale research projects to generate data that potentially could lead to further research and funding opportunities. YCCI will accept proposals in the following categories:
Translational and Interdisciplinary Research: This award is aimed at fostering interdisciplinary teams to work collaboratively on key experiments that may lead to the next phase of discovery. These projects should be strategically targeted to conduct research that will lead to the next step along the road to translation. Investigators may request up to $50,000 per year for two years of funding totaling $100,000.
Outcomes, Research into practice, and Community-Engaged Research: Ensuring that research is translated into practice is a difficult transition to navigate. This award is for comparative outcomes and community engagement projects that bridge the gap between science and the proven efficacy of treatments in order to translate these findings into practice. Investigators may request up to $25,000 per year for two years of funding totaling $50,000.
Novel Clinical and Translational Methodologies: This award is to advance technologies post discovery with an eye toward preclinical development. The aim is to provide funding for mature new technologies that are clinically viable or for the translational advancement of medical devices/treatments. These projects should be able to generate data that will facilitate industry collaboration in order to move concepts into the healthcare market. Investigators may request up to $20,000 total cost for a 12 month period. Proposals of $10-15,000 are particularly encouraged.
Established Cores: Yale has several world-class cores but conducting research that utilizes these technologies is costly. This award is for pilot projects using such established cores as flow cytometry, genomics, and imaging for research that will lead to the funding of full-fledged grants. YCCI solicits applications from Yale faculty for translational and clinical research projects that utilize the resources and expertise found in the PET Center, MMRC, Flow Cytometry, CyTOF, or YCGA. Investigators may request up to $20,000 total cost for a 12 month period.
Emerging Cores: Core technologies change as science progresses. Proposals for projects that utilize Yale’s emerging cores will fall into one of these categories:
- Center for Biomedical and Informational Technology (CBIT): Viable prototypes, animal or pilot clinical data, and a compelling business case enhance the successful commercialization of biomedical technologies. This award provides Stage 1 and Stage 2 awards to promising projects that can benefit from the expertise offered by CBIT, a collaboration between the Schools of Medicine, Management; Engineering and Applied Science; industry; and YCCI. Investigators may request up to $1,500 total cost for stage 1 and up to $50,000 for stage 2.
- Yale Center for Molecular Discovery (YCMD): For investigators interested in screening compounds but lacking the resources to carry out this research, YCCI is partnering with YCMD to offer this award for proposals of that demonstrate potential. Investigators may request up to $40,000 total cost for a 12 month period.
- Informatics: Epic is a powerful new tool in the clinical research arsenal that has yet to be harnessed. This award will involve collaboration with the Epic team and YCCI analysts for projects that utilize the EMR to conduct research utilizing the data it contains. Investigators may request up to $10,000 total cost for a 12 month period.
Deadline for LOI: December 12, 2014
THE MARY KAY FOUNDATION Innovative / Translational Cancer Research 2015
- For junior and senior faculty conducting innovative translational research in ovarian, uterine, breast or cervical cancer.
- Translational research is broadly defined as research that will provide a scientific link between laboratory research and the clinic. Ultimately, such research would lead to improvement in diagnosis, prognosis, prevention, or treatment of the cancer.
- Time to be devoted to research: Not restricted.
- $100,000 over 2 years. ($100,000)
Deadline: November 26, 2014
AMERICAN CANCER SOCIETY INSTITUTIONAL RESEARCH GRANT for New Investigators
Yale Cancer Center is pleased to announce a competition for grants for Yale Assistant Professors. The awards are to support innovative work in the broad fields of basic, translational, clinical, and prevention/control cancer research by new investigators. These grants are restricted to investigators who have not already received federal research grant support or a previous ACS-IRG award. One-year grants will provide up to $30,000 for each award. YCC members and non-members are encouraged to apply.
Application materials may be obtained by email from Jan Zulkeski (email@example.com). Applications must be submitted by 4:00pm Thursday, November 13, 2014, and funding will begin on December 15, 2014. Further information may be obtained from Dan DiMaio (firstname.lastname@example.org).
2015 TCORS Pilot Project Program Announcement
The Yale Tobacco Center of Regulatory Science (TCORS) is offering funding for pilot projects to initiate research relating to understanding tobacco additives and modified risk tobacco products through behavioral, molecular, laboratory, pharmacological, epidemiological, and economic sciences that involves humans (both clinical & epidemiological research) and animals (basic research). We are particularly interested in studies of menthol, flavors, sweeteners, and e-cigarettes and studies using novel techniques.
Yale TCORS will fund 3-5 pilot projects at the level of $25,000 to $75,000 (direct costs only). The project must be completed in 1 budget year (9/1/15-8/31/16).
Letters of intent must:
• Be typewritten, double spaced, 12 point Times New Roman font with one inch margins
• Provide a descriptive title and the name and title of the PI and key personnel
• Include a 250-word summary of the proposed project, including specific aims, the time frame needed to achieve the stated aims, and a budget estimate
• Include a brief description of how the project will support the Yale TCORS goals or the 10 FDA Research Priorities.
• Include the applicant’s signature, address, telephone and fax numbers, and email address
• Include a NIH Biosketch (PHS 398-Rev. 08/12) with a Personal Statement of the PI’s experience and interest as it relates to the proposed project.
Convert your signed Letter of Intent into a PDF file and save it as “lastname_LOI_FY2015.”
Send your letter as an email attachment to email@example.com.
All letters must be received via email by December 5, 2014 by 4:00 pm. Facsimiles will not be accepted.
Melanoma Research Alliance Grants
Established Investigator Awards
Up to $125,000 per year for 2 - 3 years.
Special Opportunity: Bristol-Myers Squibb-MRA Established Investigator Awards in Immunotherapy
Up to $125,000 per year for 2 - 3 years to conduct projects focused on advancing the immunotherapies in melanoma.
MRA Pilot Awards
$50,000 per year for 2 years for potentially transformative pilot studies.
Special Pilot Opportunity: Society for Immunotherapy of Cancer-MRA Pilot Award
$50,000 per year for 2 years potentially transformative pilot studies in the area of immunotherapy.
MRA Established Investigator Academic-Industry Partnership Awards
Up to $100,000 per year for 2 - 3 years. Industry funds and/or in-kind support (e.g., reagents, clinical grade drugs, equipment, contract services) must match but may exceed MRA funds for the award period. Industry scientists may serve as co-investigators or collaborators, but may not be PIs. (Deadline: November 21, 2014)
Special Opportunity: Amgen-MRA Established Investigator Academic-Industry Partnership Award
In collaboration with Amgen, applications are solicited for preclinical or correlative laboratory studies related to the therapeutic potential of oncolytic virus immunotherapy in melanoma, alone or in combination with immune modulators (e.g., checkpoint inhibitors) or targeted therapies. Potential biomarkers of response in local and distant tumors and immune cell-type identification/evaluation in tumors and systemic changes related to oncolytic virus immunotherapy treatment are of interest. Mechanism of action studies using in vivo imaging or molecular techniques to differentiate direct versus immune-mediated effects are encouraged. Up to $100,000 per year for 2 to 3 years from MRA may be requested.Amgen funds will match MRA funds for the award period for a total combined award amount of up to $600,000.
MRA Young Investigator Awards
Investigators within 4 years of their first academic faculty appointment.
MRA Young Investigator Awards
Up to $75,000 per year for 3 years for translational research projects.
Special Opportunity: MRA Young Investigator Award in Dermatology
Seeking applications from dermatologist young investigators who remain actively engaged in patient care and are proposing studies in melanoma prevention, diagnosis/staging, and treatment.
MRA Team Research Awards
Special Opportunity: Bristol-Myers Squibb-MRA Team Science Awards in Immunotherapy: Awards for multidisciplinary teams of two or more established PIs, along with at least one Young Investigator to conduct projects with the potential to lead to transformative advances in melanoma immunotherapies. Up to $900,000 total over 2 - 3 years may be requested.
MRA Team Science Academic-Industry Partnership Awards
These awards are designed to facilitate progress via interactions between the academic and industrial research sectors in the team setting, and will be co-funded by MRA and an industrial collaborator whose involvement is essential to the project. Multidisciplinary teams of two or more established PIs will receive up to $500,000 total over 2 - 3 years from MRA to conduct projects supported by preliminary data. Each team must include at least one Young Investigator as a co-investigator.
Application Deadline: November 21, 2014
Lion Heart Fund for Cancer Research
The Lion Hearts are committed to finding a cure for cancer, and breast cancer in particular. In keeping with this mission, they understand the value of funding bright young minds – providing them with pilot funding to kick-start high potential research projects, and/or supporting innovative work requiring bridge funding. The Yale Cancer Center/Smilow Cancer Hospital, and particularly the Breast Center, are solid partners of the Lion Hearts and have a wealth of scientists and clinicians who are working hard towards the same goal. The Lion Heart Fund for Cancer Research was developed in order to move this shared vision forward.
Yale investigators are encouraged to submit proposals of innovative, high-potential projects requiring pilot funding. Projects may be in any area of breast cancer research – basic, translational, clinical, outcomes and population science are all welcomed from any discipline or group of disciplines. A committee, comprised of scientific/medical experts from Yale Cancer Center and dedicated Lion Hearts, will review the proposals and choose those to be funded. Funding will be $20,000 for a one-year project. Indirect costs are limited to 10%. Funds may be used for salary support, equipment, materials etc. It is expected that funds will be expended over one year; however, a one-time no-cost extension will be considered. The number of projects funded will depend on the amount of funds raised the preceding year, but is estimated at 4 projects for the 2015 cycle.
Deadline for Proposals: November 15th, 2014
The Terri Brodeur Breast Cancer Foundation 2015 Granting Process
The Terri Brodeur Breast Cancer Foundation http://www.terribrodeurbreastcancerfoundation.org/ is a nonprofit organization dedicated to providing critical funding to researchers investigating breast cancer therapies and new effective patient treatment options. Terri Brodeur, the Foundation’s namesake, was diagnosed with Stage 4 Breast Cancer in June 2003.
This award is intended to support PhD, MD/PhD and MD physician scientists at early stages of their research or clinical careers to enable them to develop as independent contributors in breast cancer research. The foundation seeks to fund broadly across all relevant disciplines and as such proposals can include basic, preclinical and clinical research. The award period is for two years with an interim renewal to occur upon successful completion of the first year and demonstrated progress toward proposal objectives. Stipends are $50,000 per year, with the intention that all funds are used for direct support of the grantee or applied to direct cost of the program. Exceptions to this policy should be anticipated by the applicant or sponsor institution.
Prospective applicants are expected to submit a research plan, pre-approved by their mentor or PI, to the foundation’s Scientific Advisory Committee. The research plan must be fundamentally sound and will include statements of:
(a) Scientific and technical merit of the research question;
(b) Design, methodology, and feasibility of the study;
(c) Relevance of the proposed research plan to the applicant’s career objectives;
(d) Significance of the proposed research to breast cancer prevention, control or treatment.
A preliminary application is mandatory for those applying for a 2015-16 fellowship grant and must be submitted by November 14th 2014. Proposals should be sent electronically to the address given below:
Attn: Dr. Nicholas A. Saccomano, Ph.D.
YCC/SCH Grants for Small Projects to Improve Patient Care
Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven are pleased to announce a new program to fund small projects to improve patient care at Smilow Cancer Hospital. Monies for this program have come through our “Closer to Free” fund. Any employee at Smilow Cancer Hospital who develops a small project may apply by submitting an application for review. Projects can range from a patient education program to stress management for staff. In order to be eligible, the employee must be sponsored by a current Cancer Center Member. A listing of active cancer center members is on the web site.
Amount: $2,500 to $5,000 each
Eligibility: Employees of Smilow Cancer Hospital at Yale-New Haven
Sponsorship: Member of Yale Cancer Center
Application: Limited to 3 pages, typed, double spaced; plus budget with justification (3 copies)
- Application sheet: Project Due Date
- Project Description
- Budget Justification
Submit to Renee Gaudette: firstname.lastname@example.org
For questions, contact Dr. Ruth McCorkle by email: email@example.com
Damon Runyon Physician-Scientist Training Award Overview
Physician-scientists who are both clinically trained and expert researchers are essential to the successful translation of scientific discovery into more effective patient therapies. They have the unique capacity to blend their insights from treating patients and working in the laboratory in a way that enables and accelerates medical advances. However, the pipeline of physician-scientists is dwindling. The decline in this vital cadre of cancer researchers is occurring at a time when cancer research holds the greatest promise of improving survival and quality of life among cancer patients. A growing shortage of physician-scientists means that major laboratory research discoveries will progress to patient application ever more slowly. If the shortage continues unabated, some may not reach patient application at all, thus presenting a crisis in cancer research.
The award will be for a period of four years. Funding will be allocated to the awardee’s institution each year for the support of the scientist. Funds are to be used for stipend and/or research expenses. No part of this grant can be used for indirect costs or institutional overhead.
Year 1 - $100,000
Year 2 - $110,000
Year 3 - $120,000
Year 4 - $130,000
*Awardees still in their ACGME training years will be paid an award amount commensurate with their institutional salary based on post-graduate year (i.e., PGY6 salary). Upon completion of that training, the award amount will increase to $100,000, with a $10,000 increase for each subsequent year of the Damon Runyon award.
Application Deadline: December 1, 2014